KLF4 and NANOG are prognostic biomarkers for triple-negative breast cancer

[1] Prat A(2010)Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer Breast Cancer Res 12 R68-5685

[2] Parker JS(2005)Breast cancer molecular subtypes respond differently to preoperative chemotherapy Clin Cancer Res 11 5678-1747

[3] Karginova O(2011)Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 Ann Oncol 22 1736-321

[4] Fan C(2013)Biological subtypes of breast cancer: current concepts and implications for recurrence patterns Q J Nucl Med Mol Imaging 57 312-676

[5] Livasy C(2006)Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors Cell 126 663-2265

[6] Hershkowitz JI(2005)Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma Cancer 104 2255-1695

[7] He X(2000)C-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevance Br J Cancer 83 1688-101

[8] Perou CM(2014)Prognostic significance of NANOG and KLF4 for breast cancer Breast Cancer 21 96-5472

[9] Rouzier R(2012)Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network Cancer 118 5463-1281

[10] Perou CM(2008)Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer J Clin Oncol 26 1275-1728

[1] Prat A(2010)Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer Breast Cancer Res 12 R68-5685

[2] Parker JS(2005)Breast cancer molecular subtypes respond differently to preoperative chemotherapy Clin Cancer Res 11 5678-1747

[3] Karginova O(2011)Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 Ann Oncol 22 1736-321

[4] Fan C(2013)Biological subtypes of breast cancer: current concepts and implications for recurrence patterns Q J Nucl Med Mol Imaging 57 312-676

[5] Livasy C(2006)Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors Cell 126 663-2265

[6] Hershkowitz JI(2005)Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma Cancer 104 2255-1695

[7] He X(2000)C-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevance Br J Cancer 83 1688-101

[8] Perou CM(2014)Prognostic significance of NANOG and KLF4 for breast cancer Breast Cancer 21 96-5472

[9] Rouzier R(2012)Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network Cancer 118 5463-1281

[10] Perou CM(2008)Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer J Clin Oncol 26 1275-1728